Academic Bibliography

Show Sort by

Your filters: cql: author="Meert, Natalie" or (type exact bookEditor and editor="Meert, Natalie")

Mark
Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial

Natalie Meert, Sunny Eloot (UGent) , MARIA WATERLOOS (UGent) , Maria Van Landschoot (UGent) , Annemieke Dhondt (UGent) , Griet Glorieux (UGent) , Ingrid Ledebo and Raymond Vanholder (UGent)

(2009) NEPHROLOGY DIALYSIS TRANSPLANTATION. 24(2). p.562-570
Mark
Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

FC Barreto, DV Barreto, S Liabeuf, Natalie Meert, Griet Glorieux (UGent) , M Temmar, G Choukroun, Raymond Vanholder (UGent) and ZA Massy

(2009) CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 4(10). p.1551-1558
Mark
Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients

Constantin von zur Muhlen, Eric Schiffer, Petra Zuerbig, Marcus Kellmann, Mario Brasse, Natalie Meert, Raymond Vanholder (UGent) , Anna Dominiczak, Yung Chih Chen, Harald Mischak, et al.

(2009) JOURNAL OF PROTEOME RESEARCH. 8(1 (Sp. Iss.)). p.335-345
Mark
- journalArticle
- A1
Uremic toxins: do we know enough to explain uremia?

Raymond Vanholder (UGent) , Natalie Meert, Eva Schepers (UGent) and Griet Glorieux (UGent)

(2008) BLOOD PURIFICATION. 26(1). p.77-81
Mark
- conference
- C3
EFFECTIVE REMOVAL OF URAEMIC SOLUTES BY DIFFERENT CONVECTIVE STRATEGIES: A PROSPECTIVE TRIAL

Natalie Meert, Sunny Eloot (UGent) , Annemieke Dhondt (UGent) and Raymond Vanholder (UGent)

(2008) INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS. 31(7). p.648-648
Mark
- journalArticle
- A1
From uremic toxin retention to removal by convection: do we know enough?

Raymond Vanholder (UGent) , Natalie Meert, Eva Schepers (UGent) and Griet Glorieux (UGent)

(2008) HEMODIALYSIS: FROM BASIC RESEARCH TO CLINICAL TRIALS. 161. p.125-131
Mark
- misc
Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia (vol 22, pg 3381, 2007)

G Cohen, Griet Glorieux (UGent) , P Thornalley, Eva Schepers (UGent) , Natalie Meert, J Jankowski, Vera Jankowski, A Argiles, B Anderstam, P Brunet, et al.

(2008) NEPHROLOGY DIALYSIS TRANSPLANTATION. 23(2). p.780-780
Mark
- journalArticle
- A1
P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production

Eva Schepers (UGent) , Natalie Meert, Griet Glorieux (UGent) , Jan Goeman (UGent) , Johan Van der Eycken (UGent) and Raymond Vanholder (UGent)

(2007) NEPHROLOGY DIALYSIS TRANSPLANTATION. 22(2). p.592-596
Mark
- journalArticle
- A1
Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors

A VALLI, ME SULIMAN, Natalie Meert, Raymond Vanholder (UGent) , B LINDHOLM, P STENVINKEL, M WATANABE, P BARANY, A ALVESTRAND and B ANDERSTAM

(2007) CLINICA CHIMICA ACTA. 379(1-2). p.87-94
Mark
- journalArticle
- A1
Review on uraemic solutes II: variability in reported concentrations: causes and consequences

Raymond Vanholder (UGent) , Natalie Meert, Eva Schepers (UGent) , Griet Glorieux (UGent) , A Argiles, P Brunet, G Cohen, T Drüke, H Mischak, G Spasovski, et al.

(2007) NEPHROLOGY DIALYSIS TRANSPLANTATION. 22(11). p.3115-3121

← Previous

Academic Bibliography

Effective removal of protein-bound uraemic solutes by different convective strategies: a prospective trial

Serum Indoxyl Sulfate Is Associated with Vascular Disease and Mortality in Chronic Kidney Disease Patients

Evaluation of Urine Proteome Pattern Analysis for Its Potential To Reflect Coronary Artery Atherosclerosis in Symptomatic Patients

Uremic toxins: do we know enough to explain uremia?

EFFECTIVE REMOVAL OF URAEMIC SOLUTES BY DIFFERENT CONVECTIVE STRATEGIES: A PROSPECTIVE TRIAL

From uremic toxin retention to removal by convection: do we know enough?

Review on uraemic toxins III: recommendations for handling uraemic retention solutes in vitro - towards a standardized approach for research on uraemia (vol 22, pg 3381, 2007)

P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical production

Overestimation of advanced oxidation protein products in uremic plasma due to presence of triglycerides and other endogenous factors

Review on uraemic solutes II: variability in reported concentrations: causes and consequences

Contents

Support

Contact